Key Insights On The Throat Lozenges Market 2024 – Size, Driver, And Major Players
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033
As per The Business Research Company’s Throat Lozenges Global Market Report 2024, the throat lozenges market is expected to show significant growth in the forecast period.
The throat lozenges market has witnessed significant growth in recent years, with the market size projected to increase from $4.89 billion in 2023 to $5.16 billion in 2024, boasting a compound annual growth rate (CAGR) of 5.6%. Key factors contributing to this growth include:
- Increased incidence of throat discomfort
- Consumer awareness and self-care trends
- Preference for natural and herbal ingredients
- Change in lifestyles and environmental factors
- Marketing and branding strategies
Future Prospects
The market is poised for continued expansion, with an estimated value of $6.45 billion by 2028, representing a CAGR of 5.7%. Factors driving this growth include:
- Prevalence of respiratory conditions
- Innovation in flavor profiles
- E-commerce and online retail growth
- Health and wellness trends
- Global respiratory health awareness
Surging Prevalence Of Respiratory Diseases Drives Growth In The Throat Lozenges Market
The increasing prevalence of respiratory diseases is a key driver of market growth. Throat lozenges play a vital role in treating respiratory tract infections and diseases. For instance:
- According to the Forum of International Respiratory Societies (FIRS), around 200 million people globally suffer from chronic obstructive pulmonary disease (COPD), with roughly 3.2 million deaths annually.
- Major players in the market include GlaxoSmithKline PLC, Pfizer Inc., Reckitt Benckiser Group PLC, Sanofi S.A, and Ricola AG.
Throat Lozenges Market Advances With Innovative Products
Innovation is at the forefront of market trends, with companies introducing new and inventive products to meet consumer needs. For example:
- Taiho Pharmaceutical Co Ltd. launched PITAS throat troche, a series of film-type lozenges designed to relieve throat pain and discomfort discreetly.
- Verfora, a Switzerland-based pharmaceutical company, strengthened its consumer healthcare portfolio through the acquisition of Spagyros Ltd., a manufacturer of phytotherapy and complementary medicines, including sore throat lozenges and cold drops.
Market Segmentation and Regional Trends
The throat lozenges market is segmented by:
- Type: Hard Candy Lozenges, Soft Lozenges, Compressed Lozenges
- Ingredient: Menthol, Mint, Eucalyptus Oil, Peppermint Oil, Honey And Ginger, Lemon, Other Ingredients
- Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
- Application: Sore Throat, Cough And Cold, Throat Diseases
- North America led the global throat lozenges market in 2023, while Asia-Pacific is expected to experience the fastest growth during the forecast period.
Conclusion: Embracing Growth in Throat Lozenges Market
As respiratory health remains a global concern, the throat lozenges market continues to offer innovative solutions to address consumer needs. With a focus on product innovation, strategic acquisitions, and market expansion, companies are poised to meet the growing demand for throat discomfort relief worldwide. As trends in health and wellness evolve, the throat lozenges market remains a dynamic and essential sector of the healthcare industry, providing comfort and relief to millions of individuals globally.
View More On The Throat Lozenges Market Report 2024 – https://www.thebusinessresearchcompany.com/report/throat-lozenges-global-market-report
Request A Sample Of The Global Throat Lozenges Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=10824&type=smp